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ABSTRACT  Antiviral  interferon  activity in any one species  can be  exhibited
by a variety of substances that differ in their physical  and chemical properties,
but the nature of these differences  is not understood.  Conditions  that can lead
to  the formation  of diverse  types  of interferons  have  been  outlined.  Reasons
have  been  adduced  why,  for  certain  purposes,  purification  of  interferons  is
desirable or even necessary, and examples have been presented to show how and
to what extent  this has been  achieved.  In spite of some very high purification
factors,  not  a single interferon  has  been obtained  as  a pure substance.  There-
fore,  all available knowledge  of physical  and chemical properties  has been  ob-
tained by indirect  means.
The first interferon was discovered by Isaacs and Lindenmann (1) in 1957, and
since then many biochemists  have attempted  to purify  many interferons.  It  is
perhaps worthwhile to pause for a moment and consider why it  is sometimes
necessary,  or at least desirable,  to work with purified rather  than with crude
interferons.
WHY  PURIFY  INTERFERONS?
Experiments  with crude  interferons  have  on several  occasions led  to wrong
interpretations,  and examples that show how this danger was  sometimes over-
come  by  purification  or  other  means are  presented.  There  are at least  five
situations where the use of crude interferons is inappropriate.
Firstly,  crude interferons,  but also sera and tissue extracts from apparently
normal  animals,  culture fluids  from  uninfected  cells,  urine,  allantoic  fluid,
egg white,  agar  overlays,  etc.,  frequently  contain  other often  nonvirus-  and
nonspecies-specific  antiviral  substances  that may  simulate certain  aspects  of
interferon  action  and  may  thus  mislead  the casual  observer.  A  number  of
specific  and  nonspecific  viral antagonists  of this  nature  is  shown  in Table  I
which represents  the "list of contents"  of a recent'review  article by Wasser-
mann  (2).  But there are doubtless others,  e.g.  Buckler and Baron  (3)  showed
that  heterologous,  acid-stable,  antivaccinia  virus  activity  of  crude  mouse
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TABLE  I
SOME  NATURAL,  NONINTERFERON  VIRAL  INHIBITORS  (2)
I.  Specific  Inhibition  of Virus  Infection
A  Antibody  to the virus
B  Antibody to  the host cell
II.  Nonspecific  Inhibition  of Virus  Infection
A  a-(Neuraminic  acid)  inhibitors  of myxoviruses
B  y-Inhibitors  of myxoviruses
C  Mucopolysaccharide  inhibitor of Theiler's  virus
D  Mucoid inhibitors of mumps virus  and pneumonia virus of mice
E  Mucoid  inhibitors of bacteriophages
F  Lipid inhibitors in normal sera
G  Nonlipid  inhibitors  in normal  sera
H  Inhibitors  in the overlay  plating agar
I  Nonspecific  inhibitor  of bacteriophage  T2
J  Host-induced  modification
K  Mycoplasma contamination  of tissue culture cells
L  Inapparent  and latent infections
M Miscellaneous  factors in  the  tissue  culture system
N  Virus inactivation following  virus-cell  interaction
O  Inhibition  of plant viruses
interferon  and of mouse serum could be readily removed from chick cells by
mere washing.  The  same  process  also  eliminated,  again  from  chick  cells,  a
noninterferon  antivaccinia factor,  present in normal  allantoic fluid.  Andrews
(4)  found  that crude  chick,  calf,  monkey,  and  human  interferons  had pro-
nounced  activity  against  vaccinia  virus  in  rabbit  skin,  and  even  the  non-
infected,  heterologous  culture  fluids  themselves  were  active  in  this  system.
Similarly,  the size  of vaccinia  lesions  and  the degree  of necrosis  in monkey
skin  were  not reduced  only  by  monkey  interferon,  but also  by  crude chick
interferon.  We,  (5,  6)  in  collaboration  with  Doctors  Andrews  and  Finter,
found that crude  allantoic  chick interferon  also  had some activity in  human
embryonic  lung  cells and in mouse L cells  against rhino- and Sendai  viruses,
respectively,  but that partly purified and concentrated  interferon, with much
higher  potency in  chick  cells,  had  lost its  heterologous  activity.  Sutton  and
Tyrrell  (7)  and Sellers and Fitzpatrick  (8)  reported that crude calf interferon
inhibited  viruses in human  and  monkey  cells,  and  heterologous  activities  of
other  crude interferons  have  been  described  by  Pollikoff  et al.  (9)  and  by
by Paucker  (10).  With  hindsight,  we would  now guess  that at least some of
these  activities  were  caused  by  agents other  than  interferons  and that  they
could probably be eliminated by washing the treated cells or by some purifica-
tion step.
The second  class  of active contaminants  present  sometimes  in infected  or
normal  culture  fluids,  or  in  crude  interferon  preparations,  are  materials
capable of actually enhancing virus growth. Some of these, such as the "stimu-
lons" of Chany and his colleagues  (11,  12)  and various other factors described
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by Truden et  al.  (13),  by Sheaff and  Stewart  (14),  by Fournier  et al.  (15),
and  by Chany and Robbe-Maridor  (16), do so by antagonizing  the action of
interferons.  Other  potential  proviral  contaminants  have  been  described  by
Righthand and Karzon  (17,  18)  and by Toyoshima and Vogt  (19).
Several  naturally occurring  factors are known to block the synthesis rather
than the  action  of interferons  (20,  21)  but these  are  outside the scope  of this
discussion.
A third group of substances,  those sometimes  present  in crude interferons,
has  been  found  to  affect  the  metabolism  of  uninfected  cells  and  so  could
possibly,  directly or indirectly, also effect virus proliferation.  Isaacs et al.  (22)
thought that crude  chick interferon  inhibited  oxidative  phosphorylation  and
increased  glycolysis  of  chick  embryo  cells,  but  Lampson  et  al.  (23)  later
showed that purified  interferon  caused  no such effects.  Levy  et al.  (24) found
that crude  chick interferon  inhibited  the  synthesis  of "slowly labeled"  RNA
of chick  fibroblasts,  but later  Levy  and  Merigan  (25)  showed  that purified
interferon did not impede cellular synthesis  of DNA, RNA, or protein.  Baron
et  al.  (26)  clearly  demonstrated  that  crude  mouse  interferon  inhibited  cell
growth,  but  not by  virtue  of  its  antiviral  activity.  Sonnabend  et  al.  (27)
reported  that crude,  but  not highly  or  partly  purified,  chick  interferon  in-
hibited  the  action of Semliki  Forest  virus  RNA-polymerase.  Kerr et al.  (28)
noted cytopathic  effects and reduced ribosomal activity, after chick fibroblasts
had  been exposed  to high  concentrations  of chick interferon of a specific  ac-
tivity of about  10,000  U/mg protein; but these phenomena did not follow the
use of materials that were 3-10 times purer.
The fourth reason for the use of purified interferons is a more mundane one.
Whenever  highly  concentrated  interferon  preparations  are  to  be  used  with
either  cultured  cells  or  in  animals,  some  inert  material  must  be eliminated
because  a  crude  interferon  containing  5%  serum would  contain,  after  100-
fold  concentration,  some  400-500  mg/ml  protein,  and  it  would  not  be  an
easily injectable fluid but a viscous semisolid glue.
The  fifth  situation,  requiring  the  use  of really  pure  interferons,  concerns
certain approaches  to work on their  chemical  composition  and their physical
properties.  Except with  preparations  of very  high  purity  (a  state,  as will  be
shown later, not yet reached),  any direct chemical analysis or measurement  of
physical  parameters can only lead to questionable or valueless results. Several
such studies have,  however,  been published  but are,  in my view at least,  best
disregarded,  e.g.  the conclusion,  drawn from the absence of a peak at 280 m/u
in  the UV absorption  spectrum,  that  chick  interferon  lacks  aromatic  amino
acids  (29).  Other workers  (30)  have  published chemical  data  on chick inter-
feron and  also  a  molecular  weight  (now  known  to  be incorrect)  calculated
from  the  position  of a  visible  band  in  a  sucrose  gradient;  still  others  (23),
using  much more  highly purified  chick interferon,  published not only a UV
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absorption spectrum but also some chemical data, among them the percentage
contents of several amino acids.  We, in our turn (5),  presented the amino acid
composition  of what we  then thought to be pure chick  interferon.  Results  of
other  chemical  analyses  were  published for  calf interferon  (31),  for  a rabbit
interferon-like  substance  (32),  and  for  mouse  and monkey  interferons  (33).
Although  these  particular results  (obtained  by direct observation  of impure
interferons)  are probably of little value, it does not mean that we know nothing
of  their  chemical  and  physical  properties.  Valuable  information  has  been
obtained in an indirect manner, not by studying the interferon  itself, but from
the  effects  of various  treatments  on  the  antiviral  behavior  of these  prepara-
tions.  Such  experiments  have meaning,  and results  obtained  in  this way will
be discussed later on.
METHODS  USED  TO  PURIFY  INTERFERONS
Isaacs and his colleagues  (1,  34,  35)  showed already  in their first publications
that chick interferon was, or at least contained, protein. It  was precipitated  by
ammonium  sulfate,  it was  substantially  destroyed  by trypsin  but not  by nu-
cleases,  it was retained  by dialysis  tubing, and it could  not be sedimented  by
centrifugation  at  100,000  g.  The  observation  that interferon  was,  at least  in
part,  protein  has  guided  subsequent  purification  work,  and  most  or  all  the
methods  known  to  protein  chemists  have  been  employed.  Such  methods
are,  for  instance:  salting  out  procedures;  precipitation  of  interferon  or of
impurities  with  protein-precipitating  acids  like  trichloroacetic,  perchloric,
thiocyanic,  and  others;  precipitation with  lower alcohols  or ketones;  adsorp-
tion onto  and release from various  metal  hydroxides  or  silicates;  chromatog-
raphy on ion-exchange  resins,  -celluloses,  or -gels; gel filtration; dialysis; elec-
trophoresis  in liquid  gradients  or solid  supports;  ultracentrifugation;  electro-
focusing; and electrodecantation
Interferons  that have  been  purified  to  varying  extents  by  one  or  more  of
these  methods  include  those  from  species  as  far apart  as  chick,  mouse,  rat,
rabbit,  monkey,  and  man.  All  these  were  virus-induced;  only  Dima  et  al.
(33)  seem to have attempted to purify nonviral animal interferons.
Considerable  work has also been done on the purification of some interferon-
like substances that occur in normal and virus-infected  plants.
With  the  exception  of  chick  interferon,  none  has,  until  recently,  been
purified more than about 50-100-fold. During the last year, however,  Paucker
and  his  colleagues  (36,  37)  have  prepared  mouse  interferon  of high specific
radio-  and  bioactivities,  and  Dr.  Paucker  will  present  his  results later  on  in
this Symposium.
PURIFICATION  OF  CHICK  INTERFERON
Most  of the work in our laboratory  concerned chick interferon, and its purifi-
cation  is therefore presented in somewhat more detail.  Early work by Wagner
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(29),  Burke  (30,  38),  Zemla and Vil1ek  (39,  40),  Kreuz  and Levy  (41),  and
others did not lead to high purification.  The first highly purified chick inter-
feron was obtained  by Lampson  et al.  (23).  With  allantoic interferon  as their
starting material,  they precipitated  residual virus and some inert protein with
dilute perchloric  acid,  concentrated  the  active  material  by adsorption  onto
zinc hydroxide,  dissolved the adsorbate in dilute acid,  and removed  zinc ions
by dialysis;  then they twice chromatographed  the interferon on  CM-cellulose
and finally subjected  the peak fractions  to alkaline electrophoresis  in Pevikon.
In  this way  4500-fold  purification  was  achieved.  Merigan  et al.  (42),  using
similar  starting  material,  somewhat  modified  Lampson's  methods  by substi-
tuting  CM-Sephadex  for  CM-cellulose  and  by  eluting  the  activity from  the
ion-exchange gel by a rising pH gradient instead of stepwise.  This led to 6500-
fold purification.  Our own  early purification  work  (43,  44)  also  started with
allantoic  fluid interferon,  but we  used somewhat  different methods  after  we
had  discovered  some perhaps unexpected  properties.  We found, for example,
that chick interferon was, like serum albumin, soluble in acid aqueous metha-
nol,  ethanol,  and  acetone,  but  unlike  albumin  it was  also  soluble  in  acid
thiocyanate or iodide solutions.  After screening a number of potential adsorb-
ents,  we  found  that  the  synthetic,  micronized  Na-Al-silicates  "Alusil"  and
"Doucil"  (J.  Crosfield  and  Sons,  Warrington,  England)  adsorbed interferon
at an acid pH and released it again, somewhat  purified and concentrated,  on
suspension  in smaller volumes  of solutions  of higher pH and ionic concentra-
tion.  By making use of these findings and by combining them with some other
purification steps, allantoic interferon could be purified about 20,000-fold,  to a
specific  activity of 1.6  X  106 U/mg protein.  (Activity  was assessed  by a  CPE
protection  method,  in which  chick fibroblasts  were  challenged  with Semliki
Forest virus.)  In later work  (6)  using  tissue culture interferon,  a  more potent
and  much  cleaner  starting  material,  the  same  purification  sequences  were
found applicable.  The most highly purified interferon  obtained  again  had a
specific  activity  of  1.6  X  106  U/mg  protein,  representing  for  this  type  of
starting fluid a 3400-fold  purification.  The process is summarized in Table II.
TABLE  II
PURIFICATION  OF  CHICK  TISSUE  CULTURE  INTERFERON  (6)
Total  Pur-
units  ification  Over-all
Sample  Volume  (X  10
6
)  Specific  activity  factor  recovery
ml  1./mg protein  %
Crude culture  fluid  22,500  5.40  470  1  100
pH 7.5  0.5  M KSCN Doucil eluate  3000  4.80  1980  4  89
pH 3.5  supernatant  fluid  3000  3.60  5180  11  67
pH 2.0 supernatant  fluid  3000  2.37  15,500  33  44
Redissolved  methanol  precipitate  225  1.80  19,300  41  33
DEAE-cellulose  eluate fractions  960  1.14  132,000  281  21
CM-Sephadex  gradient  eluate  fractions  25  0.40  1,600,000  3400  7PURIFICATION  AND  MECHANISM  OF  ACTION
Yet another  method  that led  to highly  purified  chick  interferon  was  de-
veloped  by Bodo  (45).  By combining  and modifying  some of Lampson's  and
some  of Merigan's  steps,  and  by including  final  filtration  through Biogel  P-
2000,  he purified allantoic fluid interferon 8000 times.
To  test for homogeneity,  our most highly purified  interferon  preparations
were  subjected  to  polyacrylamide  gel  electrophoresis  in  alkaline  solution.
The process  was essentially  that of Davis  (47),  but without sample and spacer
gels.  On completion of the electrophoresis,  the gel column  was  cut lengthwise
into two equal  portions; one was  stained with amido  black, the other was  cut
into 2-mm long pieces  which were  individually  eluted and assayed  for inter-
feron content.  The results  of this experiment are shown in Fig.  1. The region
of peak activity coincided exactly with a sharp double band of protein,  raising
the hope that one of the two bands was  the interferon.  In order to verify this,
electrophoresis was carried out at an acid pH, following essentially the method
of Reisfeld  et  al.  (48).  At first  all  activity  was  invariably  lost,  until  it was
realized  that  persulfate,  the  material  used  by  both  Davis  and  Reisfeld  to
polymerize  their gels,  destroyed  interferon  in acid  solution.  Gels were  there-
fore  polymerized  with  riboflavin  instead  of with  persulfate,  a  modification
that permitted electrophoresis  also at an acid pH. The results obtained in this
system  are  shown  in Fig.  2.  When  the  same  starting  material  as  had  been
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FIGURES  I  and  2.  Polyacrylamide  gel  electrophoresis  of  highly  purified  chick  inter-
feron  at pH 8.9  and at pH 4.3.  1 ml samples  of interferon  (specific  activity  1.6  X  106
U/mg protein) in 0.01  M phosphate buffer pH 7.5,  each mixed with  1 ml of 40%  aqueous
sucrose,  were  applied  to gel  columns  (40  X  6.5 mm).  After  electrophoresis  (6  mA  per
column)  the  gels  were  cut lengthwise,  one-half of each was  stained  with  amido  black,
the other was cut into  20 equal portions which were individually eluted  for assay. Arrows
denote  that,  owing  to  insufficient  dilution,  assay  end  points  were  not  reached,  i.e.,
actual  interferon  contents  were higher than  those shown.
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used  for alkaline electrophoresis  was employed,  two protein zones were again
observed,  this time well separated,  but the peak  interferon activity  was situ-
ated between them and was obviously not related to either. Since the starting
material itself already had a specific activity of 1.6  X  106 U/mg protein, and
since most of the protein was present as impurity  and not as part of the inter-
feron, pure chick interferon will be found to have an extremely high specific
activity, and it must be classed among the biologically  most potent substances
so far known.  Attempts to stain similar  gels with dyes that would reveal  the
presence of neutral or acidic polysaccharides led to negative results.
Bodo  (45)  too,  found that his highly purified chick  interferon gave rise to
several protein bands after acid or alkaline electrophoresis; none  of these bands
appeared  to be associated  with the antiviral  activity.  Moreover,  when  non-
infected  allantoic  fluid  was  processed  by  the  same  methods,  he  observed
protein profiles identical with those obtained from the interferon.
During  our  purification  work we  had  several  indications  that  the  active
material in chick interferon preparations was  itself heterogeneous.  For exam-
ple,  the distribution  of activity  after  polyacrylamide  gel  electrophoresis  was
never confined to a very narrow zone, and the activity, after elution from CM-
Sephadex by a rising pH gradient,  was usually  spread over several  fractions.
We then discovered  that an early,  more acid  CM-Sephadex  eluate fraction,
after readsorption onto fresh CM-Sephadex,  again eluted at a lower pH than
did  readsorbed,  more alkaline eluate  fractions.  A possible explanation  could
have been partial methylation of the interferon during the acid methanol step
of the purification  process,  leading to artificial  heterogeneity;  it could, how-
ever,  be shown that this was not so  (6).  Further tests  (49)  proved the charge
heterogeneity  of the interferon; partly purified interferon was adsorbed onto a
CM-Sephadex column and then eluted by means of a steeply rising pH gradi-
ent.  Elution  was  not  performed  under  conditions  of equilibrium,  and  thus
there  is no direct correlation  between the isoelectric point of any of the indi-
vidual fractions  and the pH at which it was eluted  (50).  The results  of this
part of the experiment are shown in Table III.
Portions of the original eluate fractions were then readsorbed at pH 5.9 onto
fresh  CM-Sephadex  columns  and  then eluted  carefully,  this  time  stepwise
and  under  equilibrium  conditions,  with  buffers  of  rising  pH.  In order  to
eliminate errors  possibly caused  by adsorption  to a  solid matrix, some of the
original  eluate fractions were also subjected  to electrofocusing  in a liquid pH
gradient  (51).  The pH and interferon  content  of every  fraction  was  deter-
mined,  and the results obtained  from these experiments  are shown  in Table
IV. The results indicate that the interferon consisted  of five, six, or even more
components  of different  charges,  but they  do not establish  whether  there is
only one interferon adsorbed to or complexed with several differently charged
substances, or whether there are several different interferons involved.
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TABLE  III
ELUTION  FROM  A  CARBOXYMETHYL-SEPHADEX  COLUMN  OF
PARTLY  PURIFIED,  CONCENTRATED  CHICK  INTERFERON  BY
MEANS  OF  A  RISING  PH  GRADIENT  IN 0.1  M PHOSPHATE  BUFFER
Fraction code  Volume  pH  Interferon  Recovery
ml  U/ml  %
Column input
A  100  5.9  25,600  100
0.1  M Phosphate wash pH 6
B  500  6.0  <20
C  400  6.0  <20
D  100  6.0  <20
0.1  M Phosphate rising  pH eluatefractions
1  10  6.0  <20
2  10  6.0  <20
3  10  6.01  <20
4  10  6.02  <20
5  10  6.10  640  0.3
6  10  6.29  3200  1.3
7  10  6.53  6400  2.5
8  10  6.66  6400  2.5
9  10  6.79  12,800  5
10  10  6.88  12,800  5
11  10  6.96  25,600  10
12  10  7.02  12,800  5
13  10  7.11  12,800  5
14  10  7.20  12,800  5
15  10  7.28  12,800  5
16  10  7.35  6400  2.5
17  10  7.50  4800  1.9
18  10  7.62  3200  1.3
19  10  7.81  3200  1.3
20  10  8.11  6400  2.5
21  10  8.49  5400  2.5
22  10  9.78  3200  1.3
23  10  10.27  640  0.3
24  10  10.38  160  0.1
25  10  10.59  <80
26  10  10.80  <20
In view  of the recent findings  by Schonne et al.  (107)  that charge micro-
heterogeneity  of rabbit interferon was probably caused  by varying sialic acid
content,  it is likely that the same will also be found  to apply to chick inter-
feron.  On the other hand,  very many enzymes  and other biologically  active
proteins exhibit polymorphism,  and one should therefore perhaps not exclude
the  possibility  that  interferons  too  may  consist  of  groups  of closely  related
polymorphic  units.
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TABLE  IV
RECHROMATOGRAPHY  ON  CARBOXYMETHYL-SEPHADEX
COLUMN  AND  ELECTROFOCUSING  OF  INTERFERON
SOLUTIONS  OBTAINED  FROM  FIRST  CARBOXYMETHYL-
SEPHADEX  FRACTIONATION
pH of buffer
Original eluate fraction  eluting peak activity  pH of peak  ampholyte fraction
6  6.1
7  6.4  6.40
8  6.4  6.59
9  6.4
10  6.4
11  6.4  6.58
12  6.6
13  6.6  6.69
14  6.8
15  6.8  6.86
16  6.8
17  6.9  7.23
18  6.9
19  6.9
20  6.9
21  7.2  7.34
22  7.2
PURIFICATION  OF  HUMAN  AND  OTHER  INTERFERONS
We  have also  done  some work  on the purification  of human interferon  (52,
53).  The  starting  material  was  Sendai  virus-induced  leukocyte  interferon
prepared by the methods of Strander and Cantell (54, 55) and kindly donated
by Dr. Cantell. Early preparations contained  10%  human or calf serum, later
samples only 2%  human  serum.  Many,  though not all,  of the methods  used
to  purify  chick  interferon  could  also  be  applied  to  human  interferon.  But
purification,  after  every  stage,  was  much  lower  than  had  been  noted  with
chick interferon.  Two of the factors  mainly responsible  for this are probably
the presence of serum and the low isoelectric  point of the human interferon
(52,  53).  High  titers  of human  leukocyte  interferon,  in  contrast  to  those
of  chick  tissue  culture  interferon,  can  seemingly  only  be  obtained  in  the
presence  of  serum  (56),  and  some  serum  components,  physicochemically
similar to the interferon, appear to follow it during the purification processes.
The  low  isoelectric  point of the human  interferon  (see  below)  makes  chro-
matography  on  cation  exchangers,  a  key  step  in  the  purification  of chick
interferon,  a much less effective  procedure.  By choosing a suitable combina-
tion  of methods it has,  however,  proved  possible  to  concentrate  and  purify
interferon  that initially  contained  2%  serum some  40-  and 80-fold,  respec-
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tively.  Such material is being used in various experiments  in monkeys  and is
also intended for human trials in the near future (57).
Several  other  interferons  have  been  purified  in  various  laboratories  by
methods  already described or by similar techniques,  e.g.  Merigan  et al.  (42),
Lampson  (58),  and  Falcoff  et  al.  (59)  purified  various  human  interferons.
Merigan et al.  (42), Paucker and Boxaca (60),  Falcoff et al.  (61),  Golgher and
Paucker  (36),  and  Stancek  and  Paucker  (37),  and  others  purified  mouse
interferons  of diverse origin; rat interferon was purified by Denys  (62),  Cocito
et  al.  (63),  and  Schonne  (64);  many  authors,  including  Ho  (65),  Smith
and Wagner (66),  Ke and Ho  (67), and De Clercq et al,  (68)  have worked on
the purification  of rabbit interferons;  Wagner  and  Yanazaki  (69)  prepared
and purified radioactive  rabbit interferon; and Nagano et  al.  (32)  did exten-
sive  work  on  the  purification  of  interferon-like  materials  obtained  from
vaccinia  virus-infected  rabbit  skin.  Several  workers  concentrated  calf inter-
feron by nonspecific methods,  e.g.  Sutton and Tyrrell  (7) and Sellers and Fitz-
patrick  (8);  Davies  (31,  70)  subjected  it to a  number of purification  steps.
Russell  et al.  (71)  and Dima et al.  (33)  did some work on the purification of
monkey interferon.
The  only  publication  dealing  with  the  purification  of  nonvirus-induced
interferons  is  that of Dima  et  al.  (33)  who showed  that mouse and  monkey
interferons,  induced  by  Brucella suis, could  be fractionated  by  the  methods
used by others to purify virus-induced  interferons.
Most workers  have  used  well-known  separation  methods,  but there  are  a
few exceptions. Davies  (31)  adsorbed calf interferon onto small glass beads and
eluted  it with  a  mixture of organic  solvents;  Dima et al.  (33),  following  up
some  work  by  Soru and Ionescu-Stoian  (72),  used  a  mixed  CM-Sephadex/
Sephadex  G100  column  in preference  to the single  gels for  the fractionation
of mouse and monkey interferons;  De Clercq  et  al.  (68)  precipitated  various
rabbit and human  interferons  by  complexing them with yeast-RNA  in acid
solution, a  method previously  used  by Charney  (73)  for the concentration  of
poliomyelitis  viruses;  and Bocci  et al.  (74)  indicated  a  biological  procedure.
Interferon  in rabbit urine,  obtained  after intravenous  inoculation  of Sindbis
virus, was about 140 times purer than the corresponding serum interferon, and
interferonuria  was  suggested  as  an  excellent  condition  for  obtaining  highly
purified rabbit interferon.
Although work with several interferons  from other animal  species has been
described in the literature  (e.g. experiments carried out with interferons  from
guinea  pig, dog, pig, hamster,  bat, and even tortoise and fish),  no work  con-
cerning their  purification has been  reported.
MULTIPLICITY  OF  INTERFERONS
Although  the charge microheterogeneity  of chick  (49) and rabbit (107)  inter-
feron has  only recently been  recognized,  it has  been known for several years
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that cells  from one  species  are capable  of producing  more than one  type of
interferon.  At one time it was thought that viral stimuli gave rise to neutral or
slightly  acidic  interferons  of  molecular  weights  of  about  30,000,  and  that
nonviral  stimuli  produced  much  larger,  more  basic,  and  usually  less  stable
interferons.  This view has proved to be an oversimplification,  since the kind of
interferon  that is formed may  depend  on the following  other factors:  (a)  the
nature  of the inducing  stimulus  (75),  (b) whether  induced  in vivo  or in  cul-
tured cells  (76),  (c) the type of cultured cell  (77,  78, 94),  (d) the nature of the
stimulated  organ  in  the  intact  animal  (79),  (e) the  time  interval  between
stimulation  and harvest  (80),1  (f)  the presence  of stimulus  enhancers  (81),
(g)  the degree  of stimulation  (82),  and  (h) unexplained  changes with time  of
the interferon producing animal strain (83).
Investigations  under these varied conditions  have revealed  many new and
unexpected  interferons  with different  molecular  weights  or charges,  or with
different heat and acid stabilities. Often more than one interferon  is present in
one serum or  in  one  culture  fluid  specimen,  a  situation  that,  of course,  in-
creases  purification  difficulties  and that is apt,  as already  mentioned,  to con-
fuse interpretations.  In spite  of this great physicochemical  heterogeneity,  in-
terferons  belonging  to  one  animal  species  have  certain  important  features
in common. Their mode  of biological  action appears  to be the same, they are
essentially species specific (though there are exceptions [84]), and they probably
have  common  chemical features,  since Boxaca  and Paucker (85) showed that
mouse interferons,  whether large or small, whether induced in vivo or in tissue
culture by viral or nonviral  agents,  could all  be neutralized  by an antiserum
prepared against a virus-induced  tissue culture interferon.
The interrelationships  between  different interferon components  of any one
species  are not understood,  except perhaps for the charge microheterogeneity
of rabbit interferon  (107).  For example,  it is not known  whether large  mo-
lecular  interferons  are  aggregates  of  monomers  or complexes  of monomers
with inert substances,  or whether  they are  completely  unrelated  entities.  At-
tempts  to  elucidate  this  complex  problem  have  so far  only  led  to  few and
tentative results.
Davies  (70)  thought he had evidence  that his calf interferon was linked to
serum albumin;  Nagano  et al.  (32)  believe  that their high molecular  weight
rabbit interferon  is a complex  of a small active oligo-  or polysaccharide  with
inert  protein;  Merigan  and  Kleinschmidt  (76)  failed  to  disaggregate  high
molecular weight,  statolon-induced mouse interferon by exposure  to high pH
and  high  ionic  concentration;  Schonne  and  his  colleagues  (86)2  treated  a
high-molecular  weight,  NDV-induced  rabbit tissue culture  interferon with 4
M  urea and found that it was converted,  in very low yield, to a smaller unit,
I Stewart, E.,  and S. E. Sulkin.  1969.  Personal communication.
'Schonne,  E., A.  Billiau,  E. De Clercq,  and  P. De  Somer.  1969.  Personal communication.
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similar to one already present in greater abundance in the same culture fluid.
Kadri and Kohlhage  (87),  on the other  hand,  were unable  to interconvert
high and  low  molecular  weight  components  of virus-induced  rabbit  serum
interferon.  Coppey  and  Markovits3  observed  that  graded  UV-light  irradia-
tion of virus-infected  monkey kidney cells reduced  the production of low and
high  molecular  interferons  to  a  similar  extent,  from  which  they concluded
that the latter  was a  polymer of the former.  Fantes  (52,  53)  presented  some
tentative evidence  that a high molecular  weight component in virus induced
human  leukocyte  interferon  could  be an  aggregation  artifact.
The multiplicity of interferons is reminiscent of isoenzymes,  a field in which
again  several  different  molecules  appear  to perform  one  and  the same bio-
logical  function.  The  position  there  was  summarized  by  Kaplan  (88)  who
wrote: "An ever increasing number of enzymes have been reported as existing
in more than one molecular form.  In fact, it appears that the enzyme existing
in  only  one form  is  an exception."  This  could  perhaps  be  said  with equal
justification of interferons. As an example of this heterogeneity,  the properties
of a number  of rabbit interferons,  as described  by various  authors,  are  pre-
sented in Table V.
TABLE  V
MOLECULAR  WEIGHTS  AND  ISOELECTRIC  POINTS  OF  RABBIT  INTERFERONS
Origin  Inducer  IEP  Mol wt  Reference
Primary spleen  NDV  7.4  33,000  50
cells
Serum  NDV  46,000> 100,000
Serum  Endotoxin  54,000> 100,000
Urine  NDV  46,000>100,000
Urine  Endotoxin  35,000>100,000
Serum  NDV  51,000>134,000
Macrophages  NDV  37,000  45,000>134,000
Primary kidney  NDV  45,000>134,000  66
cells
Macrophages  Endotoxin  28,000  34,000  45,000
73,000> 134,000J
Serum  RNA from P. funic-  6.9-7.1  61,000  130,000  90
ulosum
Serum  Poly I:C  6.8-6.9  49,000  52,000  91
Urine  Sindbis  <8.8  - 92
RK13  NDV  40,000> 100,000  *
Serum  NDV  or PR8  41,000  53,000>100,000  87
RK13  NDV  5.07-6.69  - 107
* Schonne, E.,  A. Billiau, E. De Clercq,  and P. De Somer.  1969.  Personal communication.
3 Coppey, J.,  and P. Markovits.  1969.  Personal communication.
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PHYSICOCHEMICAL  PROPERTIES
No interferon  has so far been prepared in a pure state,  and therefore all the
facts known have been obtained  by indirect means,  i.e. by following the fate
of the biological activity under various conditions, and not from direct chemi-
cal analyses  or direct physical  observations.  However,  in view of the already
discussed multiplicity of interferons,  results obtained from work with crude or
partly  purified  interferons  should  be  carefully  scrutinized,  since  they  could
easily represent composite  values of mixtures of active components.
Molecular  weights  of  interferons  have  been  obtained  mainly  from  gel
filtration  studies  and,  to  a lesser  extent,  also from gradient centrifugations.
Polson and Vargosco4 used the rate of diffusion through stretched cellophane
to calculate the molecular weight of chick interferon.  In general,  virus-induced
interferons  have molecular  weights in the  region  25,000-35,000,  but several
minor  components  of  higher  molecular  weights  have  also  been  reported.
Interferons  obtained  after  nonviral  stimulation  often,  but not always,  have
higher molecular  weights,  but the  dividing line  between  the two  groups  of
interferons  is  by  no  means  clear-cut.  For  example,  interferons  induced  in
human  leukocytes  by  two  nonviral  stimuli  phytohemagglutinin  and  the
double-stranded  RNA  complex,  formed from  polyinosinic  and polycytidylic
acids, had molecular weights of 18,000 and 25,000, while virus-induced human
amnion interferon had a molecular weight  of about 160,000  (59).
Isoelectric  points have been determined from the pH at which interferons
could be eluted from various natural and synthetic ion-exchangers,  in particu-
lar from CM-Sephadex,  by electrophoresis  in solid supports or liquid  gradi-
ents,  and,  more  recently  also by electrofocusing  (51)  and  electrodecantation
(95).  It was first  thought  that all  virus induced  interferons  were  neutral  or
slightly  acidic  substances,  while  nonviral  interferons  were  considered  to be
more basic  (93).  Again,  this generalization  is only partly correct; e.g.  Falcoff
et al.  (61)  reported an isoelectric point of pH  8.0,  determined  by CM-Seph-
adex chromatography,  for virus induced mouse brain interferon, and Stancek
and Paucker  (108) observed  by electrofocusing a component  of virus-induced
mouse tissue culture interferon isoelectric at pH  10. Fantes (52,  53) found, by
CM-Sephadex  chromatography,  by electrofocusing,  and  by  electrodecanta-
tion,  that virus-induced  human  leukocyte  interferon was isoelectric  near pH
5.2  (with minor  peaks at pH 5.7 and pH 6.1).  Merigan  (96)  also reported  a
low  (pH  5.0-5.5)  isoelectric  point  for  virus induced  human  foreskin  inter-
feron.  In  view  of the  already  demonstrated  charge  microheterogeneities  of
chick  and rabbit interferons  (49,  107),  one  should not ignore the  possibility
4 Poison,  A.,  and A. J.  Vargosco.  1965.  Personal communication.
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that the reported isoelectric  points of some other interferons  are also those  of
the major components of polymorphic  or other mixtures.
Only little  is known  about the  chemical  make-up  of interferons,  and this
again has been established by indirect means.  From the fact that every inter-
feron so far tested was destroyed  by proteolytic, but not by other enzymes, it
is  generally  agreed  that  interferons  are  or  at  least  contain  protein.  Only
Nagano et al.  (32)  do not agree with this view.  They believe that, at least the
antiviral substance isolated by them from vaccinia virus-infected  rabbit skin,
is a protein-free  active oligo- or polysaccharide  that can be loosely bound to a
variety of inactive  proteins.  However,  both  the free saccharide  and the  sac-
charide-containing  glycoprotein  have a  number  of properties  that can  only
be reconciled with difficulty with those generally accepted for interferons. The
views  of  the Japanese  workers  were  summarized  by Nagano  (97)  and  by
Okazaki  (98),  and differences  of the factors  from other interferons  were  dis-
cussed by Fantes  (99,  100).
Carbohydrate  has also been found in hydrolysates of some other interferons,
e.g.,  by Burke  (30,  38),  Lampson  et  al.  (23),  Davies  (31),  and  Fantes  and
Furminger  (46).  These  results were  obtained  from materials  now  known  to
have been impure and thus do not prove that carbohydrate  is an integral part
of the interferon  molecule.  The activities of some of these and of some other
(e.g.  Schonne  [64]  and  Ke and  Ho [101])  interferons were  also shown to  be
sensitive to periodate.  This again suggests but does not prove the presence  of
essential  carbohydrates,  because  several  carbohydrate-free,  biologically
active  proteins  have  been  destroyed  by very  mild  periodate  treatment  (46,
102-104).  Gresser and Thomass on the other hand,  found that the addition
of several  periodate-sensitive  amino acids did not protect  mouse brain inter-
feron from destruction  by periodate,  a  result  favoring the  hypothesis  that a
sugar is an essential  part of this interferon.  The presence  of the carbohydrate
sialic acid in rabbit interferon does not appear  to be needed for antiviral  ac-
tivity  (107).
Apart from periodate,  several  other chemicals  have been used  in attempts
to throw some light onto the chemical composition of interferons.  For example,
high molarities of urea are believed  to have no effect on chick interferon  (35,
42),  but mouse  (42)  and rat  (64)  interferons  are  destroyed  by this  reagent.
Kadri and Kohlhage  (87) found that the high molecular but not the low mo-
lecular components of virus induced rabbit serum interferon  were  urea sensi-
tive.  These  results  show  that  hydrogen  bonding  is  apparently  essential  in
some but not in all interferons.
The fact that neither nucleases  nor ether inactivate interferons  suggests the
absence  of nucleic acids and lipids as  essential  parts  of interferons.
5 Gresser, I.,  and M. T.  Thomas.  1968.  Personal communication.
126  sK.  H.  FANTES  Purification and Physicochemical Aspects
Purified  chick  interferon  has been  exposed  to a number of chemicals  that
are  known  to  react,  under  defined  conditions,  with specific  amino  acids  or
with specific  bonds in protein molecules.  It was found  that  antiviral  activiy
was  destroyed by all  reagents that oxidatively  or reductively  attack disulfide
bonds,  by reagents that alter amino groups, and by cyanogen bromide, while
several other reagents did not influence the activity. From these results, Fantes
and  O'Neill  (105)  concluded  that  chick  interferon  must  have  at least  one
disulfide  bond,  at least  one  free  amino group,  and at  least one  methionine
residue,  but that hydroxyl or sulfhydryl  groups,  if present,  were nonessential
parts of the interferon  molecule.  The results of this work  are summarized  in
Tables VI  and VII. Intact  disulfide  bonds are  also  needed for  the activities
of mouse  (42),  rat (64),  and  possible  rabbit  (101)  interferons;  the latter also
contains essential  methionine  (101).
Some other  chemical or physical treatments  have an effect  on the stability
TABLE  VI
EFFECT OF SOME REAGENTS ON ANTIVIRAL  ACTIVITY OF CHICK INTERFERON
Con-  Duration of  Temp. of  Protein groups
Reagent  centration  pH  reaction  reaction  Residual  activity  primarily  attacked
mm  hr  °C  %
Acetic  anhydride  5.5  7.5  2  0-4  30,  <5,  <10  -NH 2(a),  -OH
55.0  7.5  2  0-4  20,  <5,  <10  -NH 2 (at  and  e),
-OH
Benzoylchloride  25.0  7.5  2  0-4  <5,  <10  -NH 2
Benzylchloride  25.0  7.5  2  0-4  100,  100  -NH 2 (at elevated
temp.  only)
Fluoro-dinitro-  8.1  8.0  2  0-4  65,  35  -NH 2, -OH*,
benzene  -SH
81.4  8.0  2  0-4  35,  25  -NH 2, -OH*,
-SH
Nitrous  acid  1000  4.0  0.5-0.75  0-4  15  -NH 2 ,  -SH,
-OH*
1000  4.0  1.5  0-4  10  -NH 2,  -SH,
-OH*
1000  4.0  3  0-4  5  -NH2,  -SH,
-OH*
p-Cl-mercuriben-  0.0735  6.8  0.33  Rt  100,  100,  100,  100  -SH
zoate
Performic acid  0.44  7.0  7  0-4  100,  100,  >75,  67  -S-S-
4.4  7.0  7  0-4  <5,  <5,  <5,  <5  -S-S-
Formic acid  170  7.0  7  0-4  100
Hydrogenperoxide  4.4  7.0  7  0-4  100
Phenyl-isocyanate  9.3  8.1  0.25  0-4  10,  <5  -NH 2,  --OH*
9.3  5.8  0.25  0-4  100,  50,  100,  50,  -SH
100 35, 35, 50
* -OH from  tyrosine.
: R =  room  temperature.
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TABLE  VII
EFFECT  OF  REDUCING  AND  OTHER  REAGENTS  ON  ANTIVIRAL  ACTIVITY  OF
CHICK  INTERFERON
Dura-  Temp.
Con-  tion of  of  Residual  Protein groups
Reagent  centration  pH  reaction  reaction  activity  primarily attacked
m  tM  hr  CG  %
Benzyl  mercaptan  100  5.0  8  R*  <5,  <10  -S-S--
Benzyl  mercaptan  100  5.0  72  R  <5,  <10  -S-S-
Sodium thioglycollate  1000  5.0  1  R  10,  10  -S--S-
Sodium  thioglycollate  1000  5.0  18  R  5,  <5  -S-S-
2-Mercaptoethanol  200  7.2  24  4  25,  50  -S--S-
2-Mercaptoethanol  200  7.2  24  4  20,  35  -S-S-  then -SH
followed  by iodoacetate  10  7.2  24  4
Iodoacetate  10  7.2  24  4  65,  100  -SH
Bromoacetate  5  5.0  3  37  100,  65  Imidazole  (histidine)
Bromoacetate  5  8.2  3  37  100,  100  -SH
Cysteine  25  5.0  3  37  50, 50  -S-S-
Cysteine  25  8.2  3  37  50,  50  -S-S-
Bromoacetate  +  cysteine  5+25  5.0  3  37  70, 50  Imidazole  histidine/
--S-S-
Bromoacetate  +  cysteine  5+25  8.2  3  37  40, 50  -SH/--S-S--
25
K-Cyanate  0.5  6.0  24  R  100,  100  -SH
K-Cyanate  5  6.0  24  R  100,  100  -SH
K-Cyanate  50  6.0  24  R  100,  100  -SH
Cyanogen-bromide  16.5  2.0  24  R  <5,  10  'y-S-methyl ofmethionine
* R  =  room temperature
TABLE  VIII
LOSS  OF ACTIVITY  OF CRUDE  HUMAN  LEUKOCYTE  INTERFERON  DUE  TO
SURFACE  DENATURATION  AND  PROTECTIVE  EFFECT OF ANTIFOAM  P2000
No  antifoam  Antifoam P2000  (40 ppm)
Gas  0 hr  8 hr  24 hr  48 hr  0 hr  8 hr  24 hr  48 hr
None  10,240  5120  10,240  10,240  10,240  10,240
Air  640  160  80  5120  5120  10,240
N2  1280  <320  <320  10,240  20,480  10,240
CO2 1280  <160  <160  10,240  10,240  10,240
of interferons,  without however  helping  to elucidate  their structure  or com-
position.  Most interferons are remarkably stable to acid and  heat. We found
that  beta-propiolactone  rapidly  destroyed  chick  (43)  and  human  (52,  53)
interferons  (a view not shared by Lo  Grippo and Hayashi [106]),  and we also
observed that  y-ray irradiation with a total dose of 2.69 Mrad destroyed 90%
of the activity  of crude human  leukocyte  interferon  (52,  53).  This interferon
has  been  reputed  to  be  unstable.  To ascertain  whether  instability  could  be
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attributed  to atmospheric  oxidation,  air,  nitrogen,  and carbon  dioxide  were
bubbled through samples of the interferon  (52, 53). In fact all three treatments
led to inactivation, which could not therefore have been caused  by oxidation.
The  considerable frothing noted in each of the tests raised the suspicion  that
surface inactivation  could  have taken  place. The experiments  were therefore
repeated in the presence of an antifoaming agent  (Shell P2000, a polypropyl-
ene glycol).  The antifoam  suppressed  both  frothing  and inactivation  of the
interferon.  The results  of the experiment  are  summarized  in Table VIII.
SUMMARY  AND  CONCLUSIONS
In spite of extensive work, not a single interferon has so far been obtained in a
pure state.  Therefore,  all available knowledge of physicochemical  properties
of interferons had to be derived by indirect means.
Chick  interferon,  the  most  studied  of all,  was  still  heavily  contaminated
with inert proteins  after  20,000-fold  purification.  If other  interferons  are  es-
sentially  similar  to chick  interferon  (and there are at present  no indications
that they are not) then it will take a long time before the first pure interferon
will become  available.
For  most biological  work,  existing  purified interferons  are adequate.  New
approaches  should  become  possible  with  the  advent  of  interferons  of high
radioactive  even if not of chemical purity.
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